BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Nuclear factor of activated T cells cytoplasmic calcineurin-dependent 3 (NFATc3; NFAT4)

February 18, 2016 8:00 AM UTC

Rat studies suggest inhibiting NFATc3 could help treat traumatic brain injury (TBI). In a rat model of TBI, NFATc3 and astrocytes co-localized in the hippocampus seven days post-injury. In hippocampal...